Submit Periodic Safety Update Report In Indian Population: CDSCO Panel Tells Intas on rHumanErythropoeitinalfa injection Dr. Divya Colin22 March 2024 6:00 PM ISTNew Delhi: Reviewing the proposal presented by the drug major Intas Pharmaceuticals for the revision in package insertion of rh-EPO (r Human...
Pfizer Gets CDSCO Panel Nod to Study Anti-cancer Drug PF-07220060 Dr. Divya Colin21 March 2024 6:00 PM ISTNew Delhi: The drug major Pfizer has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Submit Interim Safety, Efficacy Data: CDSCO Panel Tells Novartis on Crizanlizumab Dr. Divya Colin20 March 2024 6:00 PM ISTNew Delhi: Reviewing the status of the ongoing studies of Crizanlizumab concentrate for solution for infusion 10mg/mL (100mg/10mL), the Subject Expert...
Pfizer Gets CDSCO Panel Nod To study Osivelotor in sickle cell disease Dr. Divya Colin19 March 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to drug...
CDSCO Panel Rejects Akum Pharma's Clonazepam-Duloxetine Combination Drug Dr. Divya Colin18 March 2024 6:00 PM ISTNew Delhi: Reviewing the justification provided by the drug major Akum Pharmaceutical concerning the fixed-dose combination (FDC) Clonazepam plus...
AstraZeneca Gets CDSCO Panel Nod to Study anticancer drug Volrustomig Dr. Divya Colin17 March 2024 6:00 PM ISTNew Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
UCPMP 2024: 5 major takeaways for Indian Pharma Marketers Meghna A Singhania16 March 2024 1:50 PM ISTNew Delhi: With the Government of India announcing the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, it serves as a first...
Conduct Randomized Control Phase III CT in Indian Population: CDSCO Panel Tells Pfizer on Rimegepant Dr. Divya Colin15 March 2024 6:00 PM ISTNew Delhi: Rejecting the proposal for local Phase III clinical trial waivers, the Subject Expert Committee (SEC) functional under the Central Drug...
Abbott gets CDSCO Panel Nod To study FDC Dydrogesterone plus Estradiol Dr. Divya Colin14 March 2024 6:00 PM ISTNew Delhi: The drug major Abbott has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Centre notifies Uniform Code for Pharmaceutical Marketing Practices - UCPMP 2024 for Pharma Industry, details Garima13 March 2024 6:27 PM ISTNew Delhi: The Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, has issued the Uniform Code for Pharmaceutical Marketing...
Pregabalin Predicament: Experts advocate caution as deaths linked to anxiety drug soar Ruchika Sharma12 March 2024 1:27 PM ISTNew York: A surge in deaths associated with the widely prescribed anxiety drug, pregabalin, prompts crucial considerations, news agency PTI has...
CDSCO panel Rejects Akum Pharma's FDC Bempedoic acid plus Atorvastatin Calcium plus Ezetimibe Dr. Divya Colin11 March 2024 6:00 PM ISTNew Delhi: Reviewing the justification presented by the drug major Akum Pharmaceutical with respect to the triple-drug combination of Bempedoic acid...
